MARKET

AMPH

AMPH

Amphastar Pharma
NASDAQ
19.53
-0.04
-0.20%
After Hours: 19.53 0 0.00% 16:10 03/26 EDT
OPEN
19.50
PREV CLOSE
19.57
HIGH
19.80
LOW
18.98
VOLUME
363.47K
TURNOVER
--
52 WEEK HIGH
31.26
52 WEEK LOW
17.03
MARKET CAP
886.08M
P/E (TTM)
9.60
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AMPH last week (0316-0320)?
Weekly Report · 3d ago
Generic drug suppliers could face pressure from Strait of Hormuz closure
Seeking Alpha · 03/16 16:56
NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know
Barchart · 03/16 15:20
Amphastar Expands Share Repurchase Authorization to Manage Equity
TipRanks · 03/16 10:34
AMPHASTAR PHARMACEUTICALS INC - AUTHORIZES $50 MLN INCREASE TO SHARE BUYBACK PROGRAM ON MARCH 12, 2026 - SEC FILING
Reuters · 03/16 10:09
Weekly Report: what happened at AMPH last week (0309-0313)?
Weekly Report · 03/16 10:00
Amphastar Pharmaceuticals: Why I Like Bull Put Options Strategy Here
Seeking Alpha · 03/16 04:18
Amphastar Pharmaceuticals publishes investor presentation outlining shift to proprietary and biosimilar drug pipeline mix at 85%
Reuters · 03/10 20:43
More
About AMPH
Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable, inhalation, and intranasal products. Additionally, it sells insulin API products. Most of its finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers. The Company manufactures and sells over 25 products, such as BAQSIMI (glucagon) nasal powder 3mg, Primatene MIST, Glucagon for Injection Emergency Kit, Enoxaparin, Naloxone and Other Marketed Products, including Cortrosyn (cosyntropin for injection), Amphadase, Epinephrine injection, Lidocaine jelly, Lidocaine topical solution, Phytonadione injection, and others. The Company manufactures and sells two API products, Recombinant Human Insulin (RHI API) and porcine insulin API, for the injectable insulin market.

Webull offers Amphastar Pharmaceuticals Inc stock information, including NASDAQ: AMPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMPH stock methods without spending real money on the virtual paper trading platform.